February 1, 2012
MENLO PARK, Calif., February 1, 2012 - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year ended December 30, 2011.
For the fourth quarter of 2011, revenues before reimbursements increased 11% to $60,524,000, as compared to $54,625,000 in the fourth quarter of 2010. Total revenues increased 8% to $67,916,000, as compared to $62,602,000 in the same period one year ago.
Net income for the fourth quarter increased 25% to $7,731,000, or $0.54 per diluted share, as compared to $6,182,000, or $0.41 per diluted share, reported in the same quarter one year ago. EBITDA1 improved 20% to $14,139,000, as compared to $11,749,000 in the fourth quarter last year.
For fiscal year 2011, revenues before reimbursements increased 11% to $246,667,000, as compared to $221,860,000, in 2010. Total revenues increased 10% to $272,446,000, as compared to $248,753,000 in the prior year.
Net income for fiscal year 2011 improved 19% to $32,695,000, or $2.22 per diluted share, as compared to $27,521,000, or $1.83 per diluted share, reported in the prior year. EBITDA1 improved 16% to $58,994,000, as compared to $50,833,000, in 2010.
During 2011, Exponent generated $46.6 million in cash flow from operations, repurchased $40.6 million of its common stock, and closed the year with $109.7 million in cash, cash equivalents and short-term investments.
“The fourth quarter was a particularly good conclusion to a strong year of double-digit revenue growth and profitability for Exponent,” commented Dr. Paul Johnston, President and CEO. “During the quarter our business continued to benefit from a few major assignments and, as a result, we achieved high utilization despite our seasonally slower quarter. For both the quarter and full year we had notable performances from our mechanics and materials, electrical, thermal sciences, human factors and engineering management consulting practices, as well as our health and environmental groups.
“In 2011, we were able to leverage our breadth of disciplines and depth of engineering and scientific knowledge to assist our clients in addressing significant technological, health and environmental matters. Our defense technology development practice secured several new contracts and continued to generate solid product sales of surveillance systems. We grew our consulting staff by 7% while improving our utilization. All of these activities contributed to our strong performance for the year and we are pleased with our progress.
“For the full year 2012 we expect growth in revenue before reimbursements to be in the low- to mid-single digits. This growth has been tempered by the fact that our largest projects in 2011 accounted for a greater percentage of our revenues than in a typical year. These projects will be stepping down in their level of activity over the next several quarters. As a result we expect 2012 utilization to be lower by a percentage point or two as compared to last year and the EBITDA1 margin will be down slightly.
“As we look ahead, we will continue to expand our expertise and experience to address our clients’ important technology, health and environmental questions. We are optimistic about our market opportunities and look forward to translating these into long-term shareholder value,” concluded Dr. Johnston.
Financial Tables for Quarter-Ended December 30, 2011 and December 31, 2010 (PDF)
Today's Conference Call Information
Exponent will discuss its financial results in more detail on a conference call today, February 1, 2012, starting at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time. The audio on the conference call is available by dialing 877-941-1427 or 480-629-9664. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent web site, or by dialing 800-406-7325 or 303-590-3030, and entering reservation 4505400#.
Exponent is an engineering and scientific consulting firm providing solutions to complex problems. Exponent's multidisciplinary organization of scientists, physicians, engineers, and business consultants brings together more than 90 technical disciplines to address complicated issues facing industry and government today. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future.
Exponent may be reached at (888) 656-EXPO, email@example.com, or www.exponent.com.
This news release contains, and incorporates by reference, certain "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto under) that are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document and in the documents incorporated herein by reference, the words "anticipate," "believe," "estimate," "expect" and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading "Risk Factors" and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.
1 EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the measures to GAAP is set forth below.